Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesEffects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study
European Heart Journal, 09/03/09
Sawada T et al. – Valsartan add–on treatment to improve blood pressure control prevented more cardiovascular events than conventional non–ARB treatment in high–risk hypertensive patients in Japan. These benefits cannot be entirely explained by a difference in blood pressure control.
Related Articles
Management of Hypercholesterolemia
Geriatrics & Aging, 11/12/09
Relevance Score: 83%
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial under treatment of lipid associated cardiovascular risk?
Annals of Rheumatic Diseases, 11/11/09
Relevance Score: 82%
FDA approves Micardis as the first treatment in its class to reduce the risk of heart attack, stroke, or death from cardiovascular causes in patients at high cardiovascular risk who are unable to take ACE inhibitors
Boehringer Ingelheim, 10/20/09
Relevance Score: 82%
Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the Nurses Health Study
Arthritis Care and Research, 10/01/09
Relevance Score: 82%
Coronary heart disease can be fought by monitoring blood for lipid disorders
New York Daily News, 10/29/09
Relevance Score: 81%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Haemodynamic profile of young subjects with transient tinnitus
Audiological Medicine, 12/08/09
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Convertng Enzyme 2. Prevention of Angiotensin II–Dependent Hypertension
Hypertension, 12/07/09
Long-Term Stability of Cardiovascular and Catecholamine Responses to Stress Tests. An 18-Year Follow-Up Study
Hypertension, 12/07/09
Article Search
Sponsor